Table 1

Table.  Drugs for Prostate Cancer

 

 

Product

 

Class

 

Target

 

Clinical Stage

 

Manufacturer

 

 

ABX-EGF

 

Antibody

 

EGFR

 

Phase II

Amgen and Abgenix

 

Actimid

 

Immunomodulatory

 

Mutiple

 

Phase II

 

Celgene

 

CG7870

 

Oncolytic virus

 

Tumor cells

 

Phase I

 

Cell Genesys

 

D-63153

 

LHRH antagonist

 

LHRH

 

Phase II

 

Aeterna Zentaris

 

MDX-010

 

Antibody

 

CTLA-4

 

Phase  II

 

Medarex

 

MDX-070

 

Antibody

 

PSMA

 

Phase  II

 

Medarex

 

Subunit vaccine

 

Vaccine

 

PSMA

 

Phase I

 

Perogenics

 

Vitaxin

 

Antibody

 

Integrins

 

Phase II

 

MedImmune

Genasense (Oblimersen sodium)

 

Small molecule

 

Bcl-2

 

Phase II

 

Aventis

 

Panzem

 

Antiangiogenic

 

Microtubule

Phase II

 

EntreMed

GnRH Pharmaccine

 

Hormone

 

G-17

 

Phase II

 

Aphton

 

Perifosine

 

Kinase inhibitor

AKT/protein kinase B

 

Phase II

 

Aetera Zentaris

 

Teverelix

 

LHRH antagonist

 

LHRH

 

Phase I

 

Aetera Zentaris